| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultrasonography, Prenatal | 15 | 2021 | 904 | 3.850 |
Why?
|
| HLA Antigens | 6 | 2021 | 243 | 3.270 |
Why?
|
| Pregnancy | 42 | 2024 | 7129 | 2.060 |
Why?
|
| Pregnancy, Twin | 4 | 2018 | 173 | 1.730 |
Why?
|
| Birth Weight | 6 | 2020 | 339 | 1.450 |
Why?
|
| Pregnancy Outcome | 11 | 2020 | 596 | 1.420 |
Why?
|
| Blood Donors | 3 | 2021 | 62 | 1.340 |
Why?
|
| Pregnancy Complications, Cardiovascular | 3 | 2016 | 104 | 1.340 |
Why?
|
| Pregnancy Trimesters | 3 | 2018 | 32 | 1.320 |
Why?
|
| Fetal Weight | 3 | 2020 | 52 | 1.070 |
Why?
|
| Antibodies | 2 | 2020 | 371 | 1.020 |
Why?
|
| Histocompatibility Testing | 6 | 2017 | 148 | 0.970 |
Why?
|
| Body Mass Index | 5 | 2020 | 1550 | 0.950 |
Why?
|
| Heart Valve Diseases | 2 | 2016 | 166 | 0.920 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2023 | 439 | 0.860 |
Why?
|
| Infant, Small for Gestational Age | 3 | 2020 | 49 | 0.850 |
Why?
|
| Arthrogryposis | 2 | 2019 | 33 | 0.830 |
Why?
|
| Trial of Labor | 3 | 2019 | 21 | 0.820 |
Why?
|
| Vaginal Birth after Cesarean | 3 | 2019 | 23 | 0.810 |
Why?
|
| Social Determinants of Health | 2 | 2023 | 114 | 0.810 |
Why?
|
| Limb Deformities, Congenital | 2 | 2019 | 105 | 0.780 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 862 | 0.770 |
Why?
|
| Kidney Transplantation | 3 | 2018 | 630 | 0.750 |
Why?
|
| Placenta | 5 | 2021 | 491 | 0.740 |
Why?
|
| Fetal Development | 3 | 2018 | 112 | 0.740 |
Why?
|
| Female | 51 | 2024 | 65630 | 0.740 |
Why?
|
| Transfusion-Related Acute Lung Injury | 1 | 2020 | 2 | 0.730 |
Why?
|
| Heart Defects, Congenital | 5 | 2019 | 1803 | 0.720 |
Why?
|
| Adult | 32 | 2024 | 29093 | 0.700 |
Why?
|
| Pregnancy, Multiple | 3 | 2011 | 50 | 0.690 |
Why?
|
| Plasma | 1 | 2020 | 96 | 0.690 |
Why?
|
| Isoantibodies | 4 | 2021 | 70 | 0.680 |
Why?
|
| Clubfoot | 1 | 2019 | 19 | 0.680 |
Why?
|
| Polydactyly | 1 | 2019 | 17 | 0.670 |
Why?
|
| Fetal Growth Retardation | 2 | 2020 | 224 | 0.660 |
Why?
|
| Alleles | 4 | 2017 | 1601 | 0.650 |
Why?
|
| Humans | 60 | 2024 | 123288 | 0.640 |
Why?
|
| Extremities | 1 | 2019 | 83 | 0.640 |
Why?
|
| Fetofetal Transfusion | 2 | 2012 | 191 | 0.640 |
Why?
|
| Guidelines as Topic | 1 | 2020 | 197 | 0.630 |
Why?
|
| Chorionic Villi Sampling | 5 | 2019 | 45 | 0.620 |
Why?
|
| Twins, Dizygotic | 1 | 2018 | 41 | 0.620 |
Why?
|
| Cervix Uteri | 2 | 2017 | 69 | 0.620 |
Why?
|
| Adipose Tissue | 2 | 2018 | 465 | 0.620 |
Why?
|
| Pregnancy Trimester, Second | 4 | 2020 | 159 | 0.610 |
Why?
|
| Kidney Function Tests | 1 | 2018 | 126 | 0.600 |
Why?
|
| Allografts | 1 | 2018 | 192 | 0.580 |
Why?
|
| Monitoring, Physiologic | 3 | 2016 | 365 | 0.580 |
Why?
|
| HLA-DP beta-Chains | 1 | 2017 | 9 | 0.580 |
Why?
|
| Episiotomy | 1 | 2017 | 16 | 0.570 |
Why?
|
| Absorbent Pads | 1 | 2017 | 1 | 0.560 |
Why?
|
| Perineum | 1 | 2017 | 47 | 0.560 |
Why?
|
| Unrelated Donors | 1 | 2017 | 82 | 0.560 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 2016 | 11 | 0.550 |
Why?
|
| Genotype | 3 | 2017 | 2539 | 0.550 |
Why?
|
| Professional Staff Committees | 1 | 2016 | 6 | 0.550 |
Why?
|
| Graft Survival | 2 | 2018 | 526 | 0.550 |
Why?
|
| Obstetric Labor, Premature | 1 | 2017 | 85 | 0.550 |
Why?
|
| Peer Review | 1 | 2016 | 40 | 0.540 |
Why?
|
| Amniocentesis | 4 | 2019 | 78 | 0.530 |
Why?
|
| Benchmarking | 1 | 2017 | 132 | 0.530 |
Why?
|
| Gynecology | 2 | 2021 | 126 | 0.530 |
Why?
|
| Oxytocics | 1 | 2016 | 29 | 0.530 |
Why?
|
| Proteins | 2 | 2018 | 1040 | 0.520 |
Why?
|
| Statistics as Topic | 1 | 2017 | 251 | 0.520 |
Why?
|
| Maternal-Fetal Relations | 1 | 2016 | 14 | 0.520 |
Why?
|
| Fetal Distress | 1 | 2016 | 11 | 0.520 |
Why?
|
| Gestational Age | 6 | 2021 | 1138 | 0.520 |
Why?
|
| Labor, Induced | 1 | 2016 | 34 | 0.520 |
Why?
|
| Microarray Analysis | 4 | 2019 | 232 | 0.520 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 1140 | 0.520 |
Why?
|
| Cesarean Section | 3 | 2021 | 380 | 0.520 |
Why?
|
| Oxytocin | 1 | 2016 | 70 | 0.510 |
Why?
|
| Postpartum Hemorrhage | 1 | 2017 | 90 | 0.510 |
Why?
|
| Body Composition | 1 | 2018 | 516 | 0.510 |
Why?
|
| Energy Intake | 1 | 2018 | 490 | 0.510 |
Why?
|
| Severity of Illness Index | 2 | 2023 | 2861 | 0.500 |
Why?
|
| Bradycardia | 1 | 2016 | 59 | 0.500 |
Why?
|
| Heart Rate, Fetal | 1 | 2016 | 61 | 0.500 |
Why?
|
| Pertussis Vaccine | 1 | 2015 | 23 | 0.490 |
Why?
|
| Twins | 4 | 2013 | 68 | 0.490 |
Why?
|
| Pulmonary Edema | 1 | 2015 | 48 | 0.480 |
Why?
|
| Obstetrics | 2 | 2021 | 233 | 0.480 |
Why?
|
| Pneumothorax | 1 | 2016 | 80 | 0.480 |
Why?
|
| Biopsy | 1 | 2018 | 1236 | 0.470 |
Why?
|
| Diagnosis, Differential | 5 | 2019 | 1878 | 0.460 |
Why?
|
| Pregnancy Complications | 2 | 2016 | 504 | 0.450 |
Why?
|
| Energy Metabolism | 1 | 2018 | 774 | 0.430 |
Why?
|
| Antibodies, Bacterial | 1 | 2015 | 383 | 0.430 |
Why?
|
| Genotyping Techniques | 3 | 2017 | 101 | 0.410 |
Why?
|
| Delivery, Obstetric | 5 | 2024 | 249 | 0.410 |
Why?
|
| Graft Rejection | 2 | 2018 | 587 | 0.410 |
Why?
|
| Infant, Newborn | 10 | 2022 | 8116 | 0.400 |
Why?
|
| Biological Assay | 1 | 2013 | 100 | 0.400 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2015 | 460 | 0.370 |
Why?
|
| Heart-Lung Transplantation | 1 | 2011 | 23 | 0.370 |
Why?
|
| Amniotic Band Syndrome | 3 | 2019 | 24 | 0.370 |
Why?
|
| HLA-B Antigens | 1 | 2011 | 27 | 0.370 |
Why?
|
| Prenatal Care | 3 | 2020 | 344 | 0.370 |
Why?
|
| Umbilical Cord | 1 | 2011 | 55 | 0.370 |
Why?
|
| DNA | 1 | 2016 | 1596 | 0.370 |
Why?
|
| Critical Care | 1 | 2016 | 648 | 0.370 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2019 | 361 | 0.360 |
Why?
|
| Genetic Testing | 4 | 2019 | 999 | 0.350 |
Why?
|
| Retrospective Studies | 15 | 2024 | 16081 | 0.340 |
Why?
|
| Ciliary Motility Disorders | 2 | 2019 | 12 | 0.340 |
Why?
|
| Polycystic Kidney Diseases | 2 | 2019 | 30 | 0.340 |
Why?
|
| Vaccination | 1 | 2015 | 947 | 0.340 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2009 | 17 | 0.340 |
Why?
|
| Encephalocele | 2 | 2019 | 51 | 0.330 |
Why?
|
| Basal Metabolism | 2 | 2020 | 93 | 0.320 |
Why?
|
| Fertilization in Vitro | 2 | 2021 | 189 | 0.320 |
Why?
|
| Retinitis Pigmentosa | 2 | 2019 | 84 | 0.310 |
Why?
|
| Aneuploidy | 1 | 2009 | 154 | 0.310 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 1201 | 0.310 |
Why?
|
| Referral and Consultation | 1 | 2012 | 528 | 0.310 |
Why?
|
| Acute Lung Injury | 3 | 2014 | 62 | 0.300 |
Why?
|
| Placenta Diseases | 1 | 2008 | 57 | 0.300 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2020 | 107 | 0.300 |
Why?
|
| Tissue Donors | 1 | 2011 | 495 | 0.290 |
Why?
|
| Prospective Studies | 5 | 2018 | 6033 | 0.290 |
Why?
|
| Obstetric Labor Complications | 1 | 2008 | 92 | 0.290 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 220 | 0.280 |
Why?
|
| Reproducibility of Results | 4 | 2017 | 2845 | 0.280 |
Why?
|
| Texas | 4 | 2023 | 3558 | 0.270 |
Why?
|
| Prenatal Diagnosis | 3 | 2021 | 592 | 0.260 |
Why?
|
| Sensitivity and Specificity | 4 | 2021 | 2019 | 0.260 |
Why?
|
| Thrombocytopenia | 2 | 2019 | 226 | 0.250 |
Why?
|
| Receptors, Cytokine | 1 | 2005 | 58 | 0.250 |
Why?
|
| Megakaryocytes | 1 | 2005 | 35 | 0.250 |
Why?
|
| Perinatology | 2 | 2022 | 30 | 0.240 |
Why?
|
| Siblings | 1 | 2005 | 196 | 0.230 |
Why?
|
| RNA Splicing | 1 | 2005 | 224 | 0.230 |
Why?
|
| Enoxaparin | 1 | 2024 | 41 | 0.230 |
Why?
|
| Obesity | 2 | 2018 | 2235 | 0.220 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2024 | 59 | 0.220 |
Why?
|
| Weight Gain | 2 | 2018 | 400 | 0.220 |
Why?
|
| Transfusion Reaction | 2 | 2014 | 37 | 0.220 |
Why?
|
| Trisomy 13 Syndrome | 2 | 2019 | 18 | 0.210 |
Why?
|
| Angioedemas, Hereditary | 1 | 2022 | 8 | 0.210 |
Why?
|
| Male | 13 | 2021 | 60346 | 0.200 |
Why?
|
| Angioedema | 1 | 2022 | 22 | 0.200 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 546 | 0.200 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 1251 | 0.200 |
Why?
|
| Algorithms | 1 | 2009 | 1596 | 0.200 |
Why?
|
| Middle Aged | 9 | 2021 | 26095 | 0.190 |
Why?
|
| Venous Thromboembolism | 1 | 2024 | 160 | 0.190 |
Why?
|
| Convalescence | 1 | 2020 | 5 | 0.180 |
Why?
|
| Healthcare Disparities | 2 | 2022 | 417 | 0.180 |
Why?
|
| Risk Assessment | 5 | 2016 | 3341 | 0.180 |
Why?
|
| Prognosis | 2 | 2019 | 4518 | 0.170 |
Why?
|
| Case-Control Studies | 5 | 2020 | 3236 | 0.170 |
Why?
|
| Pallister-Hall Syndrome | 1 | 2019 | 3 | 0.170 |
Why?
|
| Minority Groups | 1 | 2022 | 249 | 0.170 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 1 | 2019 | 8 | 0.170 |
Why?
|
| Carpal Bones | 1 | 2019 | 6 | 0.170 |
Why?
|
| Breech Presentation | 1 | 2019 | 20 | 0.170 |
Why?
|
| Radius | 1 | 2019 | 25 | 0.170 |
Why?
|
| Acrocephalosyndactylia | 1 | 2019 | 22 | 0.170 |
Why?
|
| Thumb | 1 | 2019 | 29 | 0.170 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2019 | 43 | 0.170 |
Why?
|
| Exons | 2 | 2017 | 794 | 0.170 |
Why?
|
| Pierre Robin Syndrome | 1 | 2019 | 29 | 0.160 |
Why?
|
| Blood Group Incompatibility | 2 | 2016 | 27 | 0.160 |
Why?
|
| Bone Diseases, Developmental | 1 | 2019 | 58 | 0.160 |
Why?
|
| Oligohydramnios | 1 | 2019 | 46 | 0.160 |
Why?
|
| Anticoagulants | 1 | 2024 | 580 | 0.160 |
Why?
|
| Polyhydramnios | 1 | 2019 | 55 | 0.160 |
Why?
|
| Sex Distribution | 1 | 2019 | 294 | 0.160 |
Why?
|
| Body Fluid Compartments | 1 | 2018 | 18 | 0.160 |
Why?
|
| Body Water | 1 | 2018 | 89 | 0.150 |
Why?
|
| Hemorrhage | 1 | 2022 | 458 | 0.150 |
Why?
|
| Placenta Accreta | 1 | 2021 | 144 | 0.150 |
Why?
|
| Ultrasonography, Interventional | 2 | 2013 | 196 | 0.150 |
Why?
|
| Young Adult | 8 | 2019 | 8871 | 0.150 |
Why?
|
| Cerclage, Cervical | 1 | 2018 | 11 | 0.150 |
Why?
|
| Pregnancy Reduction, Multifetal | 2 | 2008 | 21 | 0.150 |
Why?
|
| Myotonic Dystrophy | 1 | 2019 | 148 | 0.150 |
Why?
|
| Apgar Score | 1 | 2018 | 47 | 0.150 |
Why?
|
| Health Information Interoperability | 1 | 2017 | 4 | 0.140 |
Why?
|
| Nutritional Requirements | 1 | 2018 | 181 | 0.140 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 310 | 0.140 |
Why?
|
| Body Height | 1 | 2018 | 211 | 0.140 |
Why?
|
| Hospitals, University | 1 | 2017 | 96 | 0.140 |
Why?
|
| Lymphocyte Depletion | 1 | 2017 | 124 | 0.140 |
Why?
|
| Reference Values | 1 | 2018 | 701 | 0.140 |
Why?
|
| Inservice Training | 1 | 2017 | 55 | 0.140 |
Why?
|
| Rho(D) Immune Globulin | 1 | 2016 | 8 | 0.140 |
Why?
|
| Postpartum Period | 1 | 2018 | 213 | 0.140 |
Why?
|
| Cell-Free System | 1 | 2016 | 106 | 0.140 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2016 | 16 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2017 | 1008 | 0.140 |
Why?
|
| Virus Diseases | 1 | 2019 | 279 | 0.140 |
Why?
|
| False Negative Reactions | 1 | 2016 | 89 | 0.140 |
Why?
|
| Emigrants and Immigrants | 1 | 2019 | 143 | 0.140 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 2115 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 285 | 0.130 |
Why?
|
| False Positive Reactions | 1 | 2016 | 145 | 0.130 |
Why?
|
| Gene Library | 1 | 2017 | 220 | 0.130 |
Why?
|
| Risk Adjustment | 1 | 2016 | 57 | 0.130 |
Why?
|
| Maternal Mortality | 1 | 2017 | 80 | 0.130 |
Why?
|
| Quality Improvement | 1 | 2022 | 626 | 0.130 |
Why?
|
| Patient Care Management | 1 | 2016 | 65 | 0.130 |
Why?
|
| Sacrum | 1 | 2016 | 29 | 0.130 |
Why?
|
| Mortality | 1 | 2017 | 228 | 0.130 |
Why?
|
| Labor, Obstetric | 1 | 2016 | 93 | 0.130 |
Why?
|
| Transplantation, Homologous | 1 | 2017 | 659 | 0.120 |
Why?
|
| Mothers | 1 | 2018 | 349 | 0.120 |
Why?
|
| Transplantation Conditioning | 1 | 2017 | 323 | 0.120 |
Why?
|
| Lumbar Vertebrae | 1 | 2016 | 109 | 0.120 |
Why?
|
| Directive Counseling | 1 | 2015 | 25 | 0.120 |
Why?
|
| Orthopedic Procedures | 1 | 2016 | 68 | 0.120 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2015 | 80 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 357 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 373 | 0.120 |
Why?
|
| Time Factors | 3 | 2016 | 6223 | 0.120 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 664 | 0.120 |
Why?
|
| Feasibility Studies | 1 | 2017 | 754 | 0.120 |
Why?
|
| Robotic Surgical Procedures | 1 | 2018 | 194 | 0.110 |
Why?
|
| Telemedicine | 1 | 2020 | 426 | 0.110 |
Why?
|
| Hypotension | 1 | 2016 | 179 | 0.110 |
Why?
|
| Hematologic Neoplasms | 1 | 2017 | 286 | 0.110 |
Why?
|
| Living Donors | 1 | 2014 | 112 | 0.110 |
Why?
|
| Guideline Adherence | 1 | 2016 | 373 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 1581 | 0.110 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 595 | 0.110 |
Why?
|
| Histocompatibility | 1 | 2013 | 46 | 0.110 |
Why?
|
| Graft vs Host Disease | 1 | 2017 | 543 | 0.110 |
Why?
|
| DNA Methylation | 1 | 2019 | 989 | 0.100 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2013 | 84 | 0.100 |
Why?
|
| Software | 1 | 2017 | 674 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1100 | 0.100 |
Why?
|
| Laparoscopy | 1 | 2018 | 501 | 0.100 |
Why?
|
| Exercise | 1 | 2018 | 814 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 6390 | 0.100 |
Why?
|
| Genome, Human | 1 | 2019 | 1263 | 0.100 |
Why?
|
| Preconception Care | 1 | 2012 | 19 | 0.100 |
Why?
|
| Decision Making | 1 | 2017 | 652 | 0.100 |
Why?
|
| Postnatal Care | 1 | 2012 | 50 | 0.100 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2012 | 34 | 0.100 |
Why?
|
| Aged | 6 | 2021 | 19180 | 0.100 |
Why?
|
| Mutation | 1 | 2005 | 5766 | 0.100 |
Why?
|
| Risk Factors | 4 | 2020 | 10033 | 0.100 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2012 | 85 | 0.090 |
Why?
|
| Abortion, Induced | 1 | 2012 | 74 | 0.090 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2012 | 172 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2015 | 543 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 1754 | 0.090 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2012 | 344 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2019 | 4692 | 0.080 |
Why?
|
| Electrocardiography | 1 | 2015 | 958 | 0.080 |
Why?
|
| Nose | 1 | 2009 | 92 | 0.080 |
Why?
|
| Adolescent | 5 | 2022 | 19129 | 0.080 |
Why?
|
| Sampling Studies | 1 | 2008 | 74 | 0.080 |
Why?
|
| Blood Platelets | 1 | 2011 | 327 | 0.080 |
Why?
|
| Fetal Monitoring | 1 | 2008 | 57 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3553 | 0.070 |
Why?
|
| Fetal Diseases | 1 | 2012 | 440 | 0.070 |
Why?
|
| Maternal Age | 1 | 2008 | 137 | 0.070 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2008 | 78 | 0.070 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 1 | 2007 | 7 | 0.070 |
Why?
|
| Potassium Chloride | 1 | 2007 | 54 | 0.070 |
Why?
|
| Hypertension, Pulmonary | 1 | 2012 | 434 | 0.070 |
Why?
|
| Survival Rate | 1 | 2012 | 2005 | 0.070 |
Why?
|
| Pregnancy, Ectopic | 1 | 2007 | 29 | 0.070 |
Why?
|
| Overweight | 1 | 2009 | 358 | 0.070 |
Why?
|
| Follow-Up Studies | 3 | 2016 | 5061 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 751 | 0.070 |
Why?
|
| Heart Transplantation | 1 | 2013 | 854 | 0.070 |
Why?
|
| Thrombopoietin | 1 | 2005 | 30 | 0.060 |
Why?
|
| Blood Cell Count | 1 | 2005 | 69 | 0.060 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2005 | 31 | 0.060 |
Why?
|
| Prevalence | 1 | 2012 | 2409 | 0.060 |
Why?
|
| Anemia, Aplastic | 1 | 2005 | 59 | 0.060 |
Why?
|
| Methotrexate | 1 | 2007 | 343 | 0.060 |
Why?
|
| Introns | 1 | 2005 | 300 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2016 | 3019 | 0.060 |
Why?
|
| United States | 4 | 2022 | 10657 | 0.060 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 788 | 0.050 |
Why?
|
| Complement C1 Inhibitor Protein | 1 | 2022 | 8 | 0.050 |
Why?
|
| Academic Medical Centers | 2 | 2016 | 299 | 0.050 |
Why?
|
| Pedigree | 1 | 2005 | 1581 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2005 | 939 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2022 | 119 | 0.050 |
Why?
|
| Gene Expression | 1 | 2005 | 1567 | 0.040 |
Why?
|
| Child | 4 | 2022 | 24269 | 0.040 |
Why?
|
| Cell Line | 1 | 2005 | 2771 | 0.040 |
Why?
|
| Upper Extremity Deformities, Congenital | 1 | 2019 | 4 | 0.040 |
Why?
|
| Aspirin | 1 | 2021 | 220 | 0.040 |
Why?
|
| Lower Extremity Deformities, Congenital | 1 | 2019 | 8 | 0.040 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2019 | 15 | 0.040 |
Why?
|
| Gambia | 1 | 2019 | 28 | 0.040 |
Why?
|
| Fanconi Anemia | 1 | 2019 | 44 | 0.040 |
Why?
|
| Cicatrix | 1 | 2021 | 125 | 0.040 |
Why?
|
| Anal Canal | 1 | 2019 | 78 | 0.040 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2019 | 19 | 0.040 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2019 | 92 | 0.040 |
Why?
|
| Central America | 1 | 2019 | 21 | 0.040 |
Why?
|
| South America | 1 | 2019 | 38 | 0.040 |
Why?
|
| Women's Health Services | 1 | 2019 | 15 | 0.040 |
Why?
|
| Spine | 1 | 2019 | 143 | 0.040 |
Why?
|
| Valproic Acid | 1 | 2019 | 165 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 768 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2019 | 113 | 0.040 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2019 | 121 | 0.040 |
Why?
|
| Mexico | 1 | 2019 | 179 | 0.040 |
Why?
|
| Politics | 1 | 2019 | 58 | 0.040 |
Why?
|
| Esophagus | 1 | 2019 | 214 | 0.040 |
Why?
|
| Trachea | 1 | 2019 | 201 | 0.040 |
Why?
|
| Disease | 1 | 2019 | 129 | 0.040 |
Why?
|
| Seasons | 1 | 2019 | 305 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2021 | 677 | 0.030 |
Why?
|
| Robotics | 1 | 2018 | 106 | 0.030 |
Why?
|
| Uterus | 1 | 2021 | 594 | 0.030 |
Why?
|
| Myosarcoma | 1 | 2016 | 2 | 0.030 |
Why?
|
| Ilium | 1 | 2016 | 20 | 0.030 |
Why?
|
| Live Birth | 1 | 2016 | 55 | 0.030 |
Why?
|
| Time | 1 | 2016 | 94 | 0.030 |
Why?
|
| Spinal Neoplasms | 1 | 2016 | 59 | 0.030 |
Why?
|
| Fetoscopy | 1 | 2019 | 439 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2016 | 333 | 0.030 |
Why?
|
| ABO Blood-Group System | 1 | 2014 | 65 | 0.030 |
Why?
|
| Myocardium | 1 | 2019 | 987 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2019 | 962 | 0.030 |
Why?
|
| Infant | 2 | 2022 | 12371 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2022 | 13928 | 0.030 |
Why?
|
| Kidney | 1 | 2019 | 1342 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2019 | 1479 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2014 | 226 | 0.030 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2013 | 120 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 586 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 1414 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2013 | 422 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 577 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2011 | 304 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2011 | 383 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 644 | 0.020 |
Why?
|
| Abortion, Therapeutic | 1 | 2007 | 4 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 2964 | 0.020 |
Why?
|
| Amnion | 1 | 2007 | 38 | 0.020 |
Why?
|
| Uterine Hemorrhage | 1 | 2007 | 46 | 0.020 |
Why?
|
| Injections | 1 | 2007 | 153 | 0.020 |
Why?
|
| Incidence | 1 | 2011 | 3055 | 0.010 |
Why?
|
| Biomarkers | 1 | 2013 | 2955 | 0.010 |
Why?
|
| Logistic Models | 1 | 2007 | 1799 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 12176 | 0.010 |
Why?
|